Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats

Clinica Chimica Acta

Volumn 287, Issue 1-2, 1999, Pages 19-27

  Kedziora Kornatowska K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidants; Diabetes; Enalapril; Kidney; Lipid peroxidation; Losartan; Oxidative stress

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CATALASE; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUTATHIONE PEROXIDASE; LOSARTAN POTASSIUM; MALONALDEHYDE; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE PEROXIDASE; KIDNEY; LIPID PEROXIDATION; LOSARTAN; MALE; MALONDIALDEHYDE; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ENA;

EID: 0345493748     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00115-1     Document Type: Article

References (32)

1. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetic Care. 15:1992;1835-1843.
2. Nath N., Chari S.N., Rathi A.B. Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes. 33:1984;586-589.
3. Chittar H.S., Nihalani K.D., Varthakavi P.K., Udipi S.A. Lipid peroxide levels in diabetics with micro- and macroangiopathies. J Nutr Biochem. 5:1994;442-445.
4. Baynes J.W. Role of oxidative stress in the development of complications in diabetes. Diabetes. 40:1991;405-412.
5. Larkins G.R., Dunlop M.E. The link between hyperglycaemia and diabetic nephropathy. Diabetologia. 35:1992;499-504.
6. Ha H., Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48:1995;18-21.
7. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 42:1993;801-813.
8. Wolf G., Thaiss F. Hyperglycaemia - pathophysiological aspects at the cellular level. Nephrol Dial Transplant. 10:1995;1109-1112.
9. Ayo S.A., Radnik G., Garoni J., Troyer D.A., Kreisberg J.I. High glucose increases diacylglycerol and activates protein kinase C in mesangial cell cultures. Am J Physiol. 26:1991;F571-F577.
10. Kreisberg J. Biology of diseases. Hyperglycaemia and microangiopathy. Direct regulation by glucose of microvascular cells. Lab Invest. 67:1992;416-426.
11. Wolf G., Neilson E.G. Angiotensin II as a renal growth factor. J Am Soc Nephrol. 3:1993;1531-1540.
12. Kreisberg J.I., Kreisberg S.H. High glucose activates protein kinase C and stimulates fibronectin expression by enhancing a cAMP response element. Kidney Int. 48:1995;S3-S11.
13. Liu F.Y., Cogan M.G. Role of protein kinase C in proximal bicarbonate absorption and angiotensin signalling. Am J Physiol. 258:1990;F927-F933.
14. Wolf G., Ziyadeh F.N. The role of angiotensin II in diabetic nephropathy. Emphasis on nonhemodynamic mechanism. Am J Kidney Dis. 29:1997;153-163.
15. Rajeswari P., Natarajan R., Ladler J.L., Kumar D., Kalra V.K. Glucose induces lipid peroxidation and inactivation of membrane-associated ion-transport enzymes in human erythrocytes in vivo and in vitro. J Cell Physiol. 149:1991;100-109.
16. Williams B., Schrier R.W. Glucose induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest. 92:1993;2889-2896.
17. Hutchison F.N., Cui X., Webster S.K. The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol. 6:1995;1216-1222.
18. Bain S.C., le Guen C.A., Lunec J. Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients. J Hum Hypertens. 5:1991;511-515.
19. Veelken R., Hilgers K.F., Mann J.F.F. The acute renal effect of angiotensin II receptor blockers. Nephrol Dial Transplant. 13:1998;1928-1929.
20. Cohen M.P., Klein C.V. Glomerulopathy in rats with streptozotocin diabetes. J Exp Med. 149:1979;623-631.
21. Del Maestro R.F., McDonald W. Oxidative enzymes in tissue homogenates. Greenwald R.A. 1986;291-296 CRC Press, Boca Raton.
22. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247:1972;3170-3175.
23. Little C., O'Brien P.J. An intracellular GSH-peroxidase with a lipid peroxide substrate. Biochem Biophys Res Commun. 31:1968;145-150.
24. Beers R., Sizer J.W. Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 195:1952;133-140.
25. Placer Z., Cushiman Z., Janson B. Estimation of products of lipid peroxidation, malondialdehyde in biochemical systems. Anal Biochem. 16:1966;359-364.
26. Shah S.V. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 35:1989;1093-1106.
27. Wohaieb S.A., Godin D.V. Alterations in free radical tissue defense mechanisms in streptozotocin-induced diabetes in rat. Diabetes. 36:1987;1014-1018.
28. Tada H., Kuboi K., lshii H., Tsukamoto M., Isogai S. Impaired degradation of hydrogen peroxide in isolated glomeruli of streptozotocin-induced diabetic rat. Diabetes. 43:(Suppl 1):1994;104A.
29. Ohkawa H., Ohishi N., Yagi R. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:1979;351-358.
30. Bakris G.L. Angiotensin-converting enzyme inhibitors in the progression of diabetic nephropathy. Ann Intern Med. 118:1993;643-644.
31. Kon V., Fogo A., Ichikawa I., Hellings S.E., Bills T. Bradykinin causes selective efferent arterial dilation during angiotensin I converting enzyme inhibition. Kidney Int. 44:1993;545-550.
32. Remuzzi A., Perico N., Amuchastegui C.S., Malanchini B., Mazerska M., Battaglia C., et al. Short and long-term effect of angiotensin receptor blockade in rats with experimental diabetes. Am J Soc Nephrol. 4:1993;40-59.